FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Arthur Kirk

(Last) (First) (Middle)
C/O SOUNDTHINKING, INC.
39300 CIVIC CENTER DR., SUITE 300

(Street)
FREMONT CA 94538

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SOUNDTHINKING, INC. [ SSTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP of Global Sales
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/18/2026   U (1) (2)   6,743 D $ 8 (1) (2) 0 D  
Common Stock 11/18/2026   D (1) (2) (3) (4)   46,852 D (1) (2) (3) (4) 0 D  
Common Stock - Performance Stock Units 11/18/2026   A (5)   112,444 A $ 0 112,444 D  
Common Stock - Performance Stock Units 11/18/2026   D (1) (2) (6)   112,444 D (1) (2) (6) 0 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $ 7.2 11/18/2026   D     30,000   (7) (8) (9) (10) (11)   (7) (8) (9) (10) (11) Common Stock 30,000 (7) (8) (9) (10) (11) 0 D  
Explanation of Responses:
1. In connection with the terms of an Agreement and Plan of Merger, dated as of September 28, 2026 (the "Merger Agreement"), by and among the Issuer, Transom Signal AcquireCo, LLC ("Parent") and Parent's wholly owned subsidiary, Transom Signal MergerSub, Inc. ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $8.00 per share, net to the stockholder, without interest (the "Closing Amount"), plus (ii) one non-transferable contingent value right per share (each, a "CVR"), which represents the contractual right to receive one contingent cash payment of up to $3.00 per CVR, net to the stockholder in cash,
2. (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a contingent value rights agreement by and among Parent, the Issuer and Equiniti Trust Company, LLC, as the rights agent (the "CVR Agreement"). After completion of the tender offer, pursuant to the terms of the Merger Agreement, the Purchaser merged with and into the Issuer (the "Merger"), effective as of November 18, 2026 (the "Effective Time"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of the Parent.
3. Represents Restricted Stock Units ("RSUs"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU that was vested and outstanding immediately prior to the Effective Time (including any RSU that vested upon the consummation of the Merger) was canceled and converted into the right to receive (A) an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of the total number of shares covered by such RSU multiplied by the Closing Amount, and (B) one CVR for each share covered by such RSU. Each outstanding unvested RSU was canceled in exchange for the right to receive (A) a restricted cash award (an "RSU Restricted Cash Award") with respect to a cash value equal to the product of the total number of shares underlying such unvested RSU multiplied by the Closing Amount and (B) one CVR for each share subject to such unvested RSU immediately prior to the Effective Time.
4. (continued from footnote 3) Both the RSU Restricted Cash Award and payments in respect of the corresponding CVR shall vest and become payable subject to the same vesting schedule and service-based forfeiture conditions as the corresponding RSU immediately prior to the Effective Time, and shall be paid in cash (without interest and less applicable tax withholding) as soon as practicable following (and in no event later than thirty (30) days after) each applicable vesting event or, in respect of the CVR, if later, the date on which payments are made to the holders of CVRs.
5. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 1, 2024 (consisting of 155,492 PSUs), February 28, 2025 (consisting of 116,194 PSUs), and May 19, 2026 (consisting of 479,760 PSUs), which vest based on revenue and adjusted EBITDA performance goals.
6. Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU that was outstanding as of the Effective Time was assumed and converted into (A) a restricted cash award (a "PSU Restricted Cash Award") with a cash value equal to the product of the total number of shares underlying such PSU multiplied by the Closing Amount, and (B) one CVR for each share subject to such PSU. Both the PSU Restricted Cash Award and any payments in respect of the corresponding CVR shall vest and become payable subject to the same vesting schedule and performance- and service-based forfeiture conditions that applied to the corresponding PSU immediately prior to the Effective Time, and shall be paid in cash (without interest and less applicable tax withholding) as soon as practicable following (and in no event later than thirty (30) days after) each applicable vesting event or, in respect of the CVR, if later, the date on which payments are made to the holders of CVRs.
7. Pursuant to the terms of the Merger Agreement, each option to purchase shares (each, an "Option") that was vested and outstanding immediately prior to the Effective Time (including any Option that vested upon the consummation of the Merger) and that has a per share exercise price less than the Closing Amount was canceled and converted into the right to receive (A) an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the total number of shares covered by such vested Option immediately prior to the Effective Time multiplied by (ii) the excess of the Closing Amount over the per share exercise price of such Option, and (B) one CVR for each share subject to such Option.
8. (continued from footnote 7) Each vested Option with a per share exercise price equal to or greater than the Closing Amount but less than the sum of the Closing Amount and the maximum aggregate CVR payment of $3.00 per CVR was canceled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the total number of shares covered by such vested Option immediately prior to the Effective Time multiplied by (ii) the cash payment a holder of one CVR would receive, as and when such payment is made to the holders of CVRs; provided that each such Option shall only receive the excess, if any, of the sum of (A) the Closing Amount plus (B) such CVR payment minus the applicable per share exercise price of such Option.
9. (continued from footnote 8) Each unvested Option with a per share exercise price less than the Closing Amount was canceled and converted into the right to receive (A) a restricted cash award with a cash value equal to (i) the total number of shares subject to such Option immediately prior to the Effective Time, multiplied by (ii) the excess of the Closing Amount over the per share exercise price of such Option, and (B) one CVR for each share subject to such Option immediately prior to the Effective Time. Each such restricted cash award and any amounts payable with respect to the corresponding CVR will continue to be subject to the same vesting terms and conditions as applied to the corresponding unvested Option immediately prior to the Effective Time.
10. (continued from footnote 9) Each unvested Option with a per share exercise price that was equal to or greater than the Closing Amount and less than the sum of the Closing Amount and the maximum aggregate CVR payment of $3.00 was canceled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the total number of shares subject to such Option immediately prior to the Effective Time, multiplied by (ii) the total cash payments a holder of one CVR would have received, as and when such CVR payment is made to the holders of CVRs, which shall equal, for each share subject to such Option immediately prior to the Effective Time, the excess, if any, of the sum of (A) the Closing Amount minus the applicable exercise price of such Option plus (B) such CVR payment.
11. (continued from footnote 10) Each such award will continue to be subject to the same vesting terms and conditions as applied to the corresponding unvested Option immediately prior to the Effective Time. Any Options with an exercise price equal to or greater than the sum of the Closing Amount and $3.00 were canceled for no consideration.
/s/ Alan R. Stewart, Attorney-in-Fact 11/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.